» Authors » Margarete Scherer

Margarete Scherer

Explore the profile of Margarete Scherer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 27
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Klingmuller A, Feldmann M, Rohr S, Helmhold L, Junker L, Scherer M, et al.
Infection . 2025 Mar; PMID: 40067569
Purpose: Tuberculosis (TB) remains a leading cause of morbidity and mortality, with 1.3 million deaths in 2022. Extrapulmonary tuberculosis (EPTB) accounts for approximately 20% of all TB cases. We assessed...
2.
Grikscheit K, Berger A, Rabenau H, Kohmer N, Appel K, Scherer M, et al.
Emerg Microbes Infect . 2025 Jan; 14(1):2459137. PMID: 39868965
Viremia defined as detectable SARS-CoV-2 RNA in the blood is a potential marker of disease severity and prognosis in COVID-19 patients. Here, we determined the frequency of viremia in serum...
3.
Xiang W, Steinbeis F, Dhindsa K, Kurth F, Lingscheid T, Thibeault C, et al.
Clin Infect Dis . 2025 Jan; PMID: 39792903
Background: Existing risk evaluation tools underperform in predicting intensive care unit (ICU) admission for patients with the Coronavirus Disease 2019 (COVID-19). This study aimed to develop and evaluate an accurate...
4.
Hoffmann A, Kobbe R, Denz R, Maier C, Toepfner N, Timmesfeld N, et al.
Eur J Pediatr . 2024 Dec; 184(1):64. PMID: 39636479
Conclusion: Accompanying adults often rate the general health and well-being of Ukrainian refugee minors as rather poor. Frequently, self-reported vaccinations and preexisting diseases did not match serology results; therefore, Ukrainian...
5.
Tscharntke L, Jung N, Hanses F, Koll C, Pilgram L, Rieg S, et al.
Infection . 2024 Aug; 53(1):259-269. PMID: 39150640
Purpose: This study investigates the care provision and the role of infectious disease (ID) specialists during the coronavirus disease-2019 (COVID-19) pandemic. Methods: A survey was conducted at German study sites...
6.
Appel K, Lee C, de Miranda S, Maier D, Reese J, Anton G, et al.
Sci Rep . 2024 Jun; 14(1):13607. PMID: 38871878
Fair allocation of funding in multi-centre clinical studies is challenging. Models commonly used in Germany - the case fees ("fixed-rate model", FRM) and up-front staffing and consumables ("up-front allocation model",...
7.
Hopff S, Appel K, Miljukov O, Schneider J, Addo M, Bals R, et al.
Infection . 2024 May; 52(6):2253-2267. PMID: 38700656
Purpose: The influence of new SARS-CoV-2 variants on the post-COVID-19 condition (PCC) remains unanswered. Therefore, we examined the prevalence and predictors of PCC-related symptoms in patients infected with the SARS-CoV-2...
8.
Appel K, Nurnberger C, Bahmer T, Forster C, Polidori M, Kohls M, et al.
Infection . 2024 Apr; 52(5):1813-1829. PMID: 38587752
Purpose: The objective examination of the Post-COVID syndrome (PCS) remains difficult due to heterogeneous definitions and clinical phenotypes. The aim of the study was to verify the functionality and correlates...
9.
Brinkmann F, Friedrichs A, Behrens G, Behrens P, Berner R, Caliebe A, et al.
J Infect Public Health . 2024 Mar; 17(4):642-649. PMID: 38458134
Background: Vulnerability to infectious diseases in refugees is dependent on country of origin, flight routes, and conditions. Information on specific medical needs of different groups of refugees is lacking. We...
10.
Tilch K, Hopff S, Appel K, Kraus M, Lorenz-Depiereux B, Pilgram L, et al.
BMC Med Ethics . 2023 Oct; 24(1):84. PMID: 37848886
With the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), global researchers were confronted with major challenges. The German National Pandemic Cohort Network (NAPKON) was launched in fall 2020...